|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/138 | |
| A61K 31/403 | |||
| A61K 31/5377 | |||
| A61K 45/06 | |||
| A61P 25/34 | |||
| A61K 9/68 | |||
| A61K 9/70 |
| (11) | Patento numeris | 2665741 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12734378.8 |
| Europos patento paraiškos padavimo data | 2012-01-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/020590 |
| Data | 2012-01-09 |
| (87) | Numeris | WO 2012/096866 |
| Data | 2012-07-19 |
| (30) | Numeris | Data | Šalis |
| 201161431308 P | 2011-01-10 | US |
| (72) |
BOND, Richard, A., US
GLASS, Mitchell, US
|
| (73) |
Invion, Inc,
Unit 2, 120 Bluestone Circuit,, Seventeen Mile Rocks, QLD 4073,
AU
|
| (54) | USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION |
| USE OF BETA-ADRENERGIC INVERSE AGONISTS FOR SMOKING CESSATION |